| Product Code: ETC9971265 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Neglected Tropical Diseases Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Neglected Tropical Diseases Treatment Market - Industry Life Cycle |
3.4 United States (US) Neglected Tropical Diseases Treatment Market - Porter's Five Forces |
3.5 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.6 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By Administration, 2021 & 2031F |
3.8 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 United States (US) Neglected Tropical Diseases Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness and advocacy efforts for neglected tropical diseases in the US |
4.2.2 Government initiatives and funding support for research and development of treatments |
4.2.3 Growing partnerships between pharmaceutical companies and non-profit organizations to address neglected tropical diseases |
4.3 Market Restraints |
4.3.1 Limited access to healthcare in certain regions of the US |
4.3.2 Regulatory challenges and approval processes for new treatments |
4.3.3 Lack of financial incentives for pharmaceutical companies to invest in neglected tropical diseases treatments |
5 United States (US) Neglected Tropical Diseases Treatment Market Trends |
6 United States (US) Neglected Tropical Diseases Treatment Market, By Types |
6.1 United States (US) Neglected Tropical Diseases Treatment Market, By Disease Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Disease Type, 2021- 2031F |
6.1.3 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Mediterranean Fever, 2021- 2031F |
6.1.4 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Ebola Virus Infection, 2021- 2031F |
6.1.5 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Chagas Disease, 2021- 2031F |
6.1.6 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Zika Virus Infection, 2021- 2031F |
6.1.7 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Chikungunya, 2021- 2031F |
6.1.8 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Neglected Tropical Diseases Treatment Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Drugs, 2021- 2031F |
6.2.3 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Vaccine, 2021- 2031F |
6.3 United States (US) Neglected Tropical Diseases Treatment Market, By Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Injectable, 2021- 2031F |
6.4 United States (US) Neglected Tropical Diseases Treatment Market, By End use |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Clinical Labs, 2021- 2031F |
6.4.3 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Hospitals /Clinics, 2021- 2031F |
6.4.4 United States (US) Neglected Tropical Diseases Treatment Market Revenues & Volume, By Home Healthcare, 2021- 2031F |
7 United States (US) Neglected Tropical Diseases Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Neglected Tropical Diseases Treatment Market Export to Major Countries |
7.2 United States (US) Neglected Tropical Diseases Treatment Market Imports from Major Countries |
8 United States (US) Neglected Tropical Diseases Treatment Market Key Performance Indicators |
8.1 Number of patients receiving treatment for neglected tropical diseases in the US |
8.2 Funding allocated by the government and non-profit organizations for research and development |
8.3 Number of partnerships formed between pharmaceutical companies and non-profit organizations to address neglected tropical diseases |
9 United States (US) Neglected Tropical Diseases Treatment Market - Opportunity Assessment |
9.1 United States (US) Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
9.2 United States (US) Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Neglected Tropical Diseases Treatment Market Opportunity Assessment, By Administration, 2021 & 2031F |
9.4 United States (US) Neglected Tropical Diseases Treatment Market Opportunity Assessment, By End use, 2021 & 2031F |
10 United States (US) Neglected Tropical Diseases Treatment Market - Competitive Landscape |
10.1 United States (US) Neglected Tropical Diseases Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Neglected Tropical Diseases Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |